Inventiva (IVA) Short Interest Ratio & Short Volume → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free IVA Stock Alerts $3.70 +0.05 (+1.37%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Inventiva Short Interest DataCurrent Short Volume68,400 sharesPrevious Short Volume77,700 sharesChange Vs. Previous Month-11.97%Dollar Volume Sold Short$216,144.00Short Interest Ratio / Days to Cover1.7Last Record DateApril 30, 2024Outstanding Shares52,480,000 sharesPercentage of Shares Shorted0.13%Today's Trading Volume11,311 sharesAverage Trading Volume31,645 sharesToday's Volume Vs. Average36% Short Selling Inventiva ? Sign up to receive the latest short interest report for Inventiva and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIVA Short Interest Over TimeIVA Days to Cover Over TimeIVA Percentage of Float Shorted Over Time Ad Manward PressAmazon's betting big on this unknown AI companyAmazon's Betting Big on This Unknown AI Company Amazon has just made a stunning $144 million investment in one small AI company.Discover why this company Inventiva Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202468,400 shares $216,144.00 -12.0%N/A1.7 $3.16 4/15/202477,700 shares $254,856.00 +34.9%N/A2 $3.28 3/31/202457,600 shares $208,512.00 -52.8%N/A1.5 $3.62 3/15/2024121,900 shares $511,980.00 +14.5%N/A3.5 $4.20 2/29/2024106,500 shares $385,530.00 +20.8%N/A5.1 $3.62 2/15/202488,200 shares $351,036.00 -0.3%N/A5.2 $3.98 Get the Latest News and Ratings for IVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inventiva and its competitors with MarketBeat's FREE daily newsletter. 1/31/202488,500 shares $336,300.00 +8.3%N/A8.3 $3.80 1/15/202481,700 shares $361,931.00 +14.1%N/A8.2 $4.43 12/31/202371,600 shares $323,345.60 -12.2%N/A7.4 $4.52 12/15/202381,500 shares $339,040.00 -2.7%N/A9 $4.16 11/30/202383,800 shares $347,770.00 -6.6%N/A7.8 $4.15 11/15/202389,700 shares $349,830.00 -1.2%N/A6 $3.90 10/31/202390,800 shares $343,405.60 +14.7%N/A5.8 $3.78 10/15/202379,200 shares $316,800.00 +4.4%N/A4.2 $4.00 9/30/202375,900 shares $318,780.00 -16.5%N/A3.7 $4.20 9/15/202390,900 shares $336,330.00 -5.6%N/A3.6 $3.70 8/31/202396,300 shares $365,940.00 +12.6%N/A0.7 $3.80 8/15/202385,500 shares $307,800.00 -7.1%N/A0.6 $3.60 7/31/202392,000 shares $376,280.00 -18.1%N/A0.6 $4.09 7/15/2023112,300 shares $478,398.00 -18.7%N/A0.8 $4.26 6/30/2023138,200 shares $558,328.00 +22.5%N/A0.9 $4.04 6/15/2023112,800 shares $516,624.00 +48.6%N/A0.8 $4.58 5/31/202375,900 shares $299,425.50 +10.0%N/A2.2 $3.95 5/15/202369,000 shares $186,300.00 -64.6%N/A3.7 $2.70 4/30/2023194,800 shares $529,856.00 -8.0%N/A12 $2.72 4/15/2023211,700 shares $642,678.86 +6.5%N/A19.4 $3.04 3/31/2023198,700 shares $723,268.00 +7.9%N/A20.3 $3.64 3/15/2023184,100 shares $741,923.00 -6.1%N/A27.1 $4.03 2/28/2023196,000 shares $1.00 million -0.2%N/A35.6 $5.11 2/15/2023196,300 shares $1.21 million +2.2%N/A29.7 $6.15 1/31/2023192,100 shares $1.20 million -0.2%0.5%25.6 $6.22 1/15/2023192,500 shares $1.16 million -0.1%0.5%20.3 $6.05 12/30/2022192,700 shares $859,442.00 -0.8%0.5%3.9 $4.46 12/15/2022194,300 shares $790,801.00 +2.8%N/A3.8 $4.07 11/30/2022189,000 shares $789,075.00 +27.4%0.5%3.5 $4.18 11/15/2022148,300 shares $647,329.50 -7.9%0.4%2.8 $4.37 10/31/2022161,000 shares $737,380.00 +1.7%0.4%3.2 $4.58 10/15/2022158,300 shares $883,314.00 +10.8%0.4%3.2 $5.58 9/30/2022142,900 shares $562,039.99 +4.2%0.4%3.1 $3.93 9/15/2022137,100 shares $534,690.00 -0.4%0.4%18 $3.90The most important AI company you've never heard of (Ad)Because this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.Get the full story on this secret AI company poised for massive growth IVA Short Interest - Frequently Asked Questions What is Inventiva's current short interest? Short interest is the volume of Inventiva shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 68,400 shares of IVA short. Learn More on Inventiva's current short interest. What is a good short interest ratio for Inventiva? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IVA shares currently have a short interest ratio of 2.0. Learn More on Inventiva's short interest ratio. Is Inventiva's short interest increasing or decreasing? Inventiva saw a decline in short interest in April. As of April 30th, there was short interest totaling 68,400 shares, a decline of 12.0% from the previous total of 77,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Inventiva's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Inventiva: Organigram Holdings Inc. (5.87%), Atossa Therapeutics, Inc. (9.13%), Acrivon Therapeutics, Inc. (5.22%), Incannex Healthcare Inc. (0.48%), Lifecore Biomedical, Inc. (6.60%), Zevra Therapeutics, Inc. (6.15%), Trevi Therapeutics, Inc. (1.49%), Galectin Therapeutics Inc. (7.35%), Greenwich LifeSciences, Inc. (3.24%), Conduit Pharmaceuticals Inc. (0.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Inventiva stock? Short selling IVA is an investing strategy that aims to generate trading profit from Inventiva as its price is falling. IVA shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Inventiva? A short squeeze for Inventiva occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IVA, which in turn drives the price of the stock up even further. How often is Inventiva's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IVA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Organigram Short Interest Data Atossa Therapeutics Short Interest Data Acrivon Therapeutics Short Interest Data Incannex Healthcare Short Interest Data Lifecore Biomedical Short Interest Data Zevra Therapeutics Short Interest Data Trevi Therapeutics Short Interest Data Galectin Therapeutics Short Interest Data Greenwich LifeSciences Short Interest Data Conduit Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IVA) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts